Recursion Pharmaceuticals (RXRX) Capital Expenditures (QoQ) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.94% |
| Dec 31, 2025 | -205.30% |
| Sep 30, 2025 | 416.25% |
| Jun 30, 2025 | -185.64% |
| Mar 31, 2025 | 41.14% |
| Dec 31, 2024 | -89.04% |
| Sep 30, 2024 | 294.10% |
| Jun 30, 2024 | -191.75% |
| Mar 31, 2024 | -44.35% |
| Dec 31, 2023 | 199,350.00% |
| Sep 30, 2023 | 99.88% |
| Jun 30, 2023 | -199.88% |
| Mar 31, 2023 | 306.83% |
| Dec 31, 2022 | -131.45% |
| Sep 30, 2022 | -543.45% |
| Jun 30, 2022 | -103.87% |
| Mar 31, 2022 | -2.73% |
| Dec 31, 2021 | -54.01% |
| Sep 30, 2021 | -61.06% |
| Jun 30, 2021 | 3,435.18% |